Andere Sprachen Renovaro Inc.

Aktien

A2PBYQ

US29350E1047

RENB

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 26.04.2024			% 5 Tage	% 1. Jan.
1.53 ^USD	-10.00%		-29.49%	-51.74%

24.04.	Renovaro's RenovaroCube ändert Vereinbarung zum Erwerb einer 100%-Beteiligung an Cyclomics	MT
18.04.	Renovaro Inc. kündigt Geert Kazemier, MD, PhD, als neuen Vorsitzenden des wissenschaftlichen Beirats an	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

RENOVARO - RENOVAROCUBE TO ACQUIRE 100% OWNERSHIP OF CYCLOMICS, REINFORCING CUTTING-EDGE CANCER DIAGNOSTICS PARTNERSHIP	25.04.
Renovaro's RenovaroCube Amends Agreement to Acquire 100% Stake in Cyclomics	24.04.
RenovaroCube to Acquire 100% Ownership of Cyclomics, Reinforcing Cutting-Edge Cancer Diagnostics Partnership	24.04.
Renovaro Inc. Proudly Announces the Appointment Of Professor Dr. Geert Kazemier as the Chairman of its Scientific Advisory Board, A Move That Heralds a New Era of Innovation and Progress in its Mission to Reshape Cancer Screening, Diagnosis, and Patient Care	18.04.
Renovaro Inc. Announces Geert Kazemier, MD, PhD, as the New Chairman of its Scientific Advisory Board	18.04.
Renovaro Inc. Appoints Simon Tarsh as Interim Chief Financial Officer	13.03.
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Renovaro Biosciences Inc. - RENB	12.03.
Renovaro Inc. Announces Resignation of Luisa Puche as Chief Financial Officer, Effective as of March 21, 2024	05.03.
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Renovaro Biosciences Inc. - RENB	03.03.
ROSEN, LEADING INVESTOR COUNSEL, Encourages Renovaro Biosciences Inc. Investors to Inquire About Securities Class Action Investigation - RENB	25.02.
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Renovaro Biosciences Inc. - RENB	24.02.
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Renovaro Biosciences Inc. Investors to Inquire About Securities Class Action Investigation - RENB	17.02.
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Renovaro Biosciences Inc. - RENB	16.02.
Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace	15.02.
Renovaro Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	14.02.
Renovaro Inc. Announces Board Changes	14.02.
Sector Update: Health Care Stocks Gain Late Afternoon	14.02.
Sector Update: Health Care	14.02.
Renovaro Shares Jump After Response to Short Seller Hindenburg's Report	14.02.
Statement of Renovaro Inc	14.02.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Renovaro Inc.

Aktien

A2PBYQ

US29350E1047

RENB

Andere Sprachen

Filter